Catalyst Wire Dossier Catalyst Wire Dossier

KAZANO

alogliptin and metformin hydrochloride · Takeda Pharmaceuticals America, Inc.
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for KAZANO, covering 2013-01-25 to 2026-08-11. Get the full timeline:

Most recent: FDA Approved: KAZANO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

See pricing